$ANEB Potential Breakout I'm not sure if I'm charting this correctly but I think this stock broke above the trend line into the upside in the post market hours.
−0.41USD
−11.73 MUSD
9.28 M
About Anebulo Pharmaceuticals, Inc.
Sector
CEO
Richard Anthony Cunningham
Headquarters
Lakeway
Website
Employees (FY)
2
Founded
2020
ISIN
US0345691036
FIGI
BBG00ZWY5GC8
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, ANEB-001, is currently in phase two of trial. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ANEB is 2.77 USD — it has decreased by 2.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Anebulo Pharmaceuticals, Inc. stocks are traded under the ticker ANEB.
Anebulo Pharmaceuticals, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ANEB stock is 3.64% volatile and has beta coefficient of −0.96. Check out the list of the most volatile stocks — is Anebulo Pharmaceuticals, Inc. there?
One year price forecast for Anebulo Pharmaceuticals, Inc. has a max estimate of 8.00 USD and a min estimate of 4.00 USD.
ANEB earnings for the last quarter are −0.10 USD per share, whereas the estimation was −0.12 USD resulting in a 14.38% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Anebulo Pharmaceuticals, Inc. earnings.
Yes, you can track Anebulo Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ANEB stock has fallen by 7.36% compared to the previous week, the month change is a 14.46% rise, over the last year Anebulo Pharmaceuticals, Inc. has showed a 5.78% decrease.
ANEB net income for the last quarter is −2.72 M USD, while the quarter before that showed −2.48 M USD of net income which accounts for −9.53% change. Track more Anebulo Pharmaceuticals, Inc. financial stats to get the full picture.
Today Anebulo Pharmaceuticals, Inc. has the market capitalization of 73.91 M, it has decreased by 1.77% over the last week.
No, ANEB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ANEB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Anebulo Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 2.00 employees. See our rating of the largest employees — is Anebulo Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Anebulo Pharmaceuticals, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Anebulo Pharmaceuticals, Inc. stock shows the neutral signal. See more of Anebulo Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Anebulo Pharmaceuticals, Inc. future price: according to them, ANEB price has a max estimate of 8.00 USD and a min estimate of 4.00 USD. Read a more detailed Anebulo Pharmaceuticals, Inc. forecast: see what analysts think of Anebulo Pharmaceuticals, Inc. and suggest that you do with its stocks.